ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.

BMC Cancer · 2020 · PMC7487553 · PMID 32891122

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

markedly significantno p-value reported

Furthermore, abnormal expression of ERCC6L was associated with shorter OS compared with low ERCC6L expression in patients, indicating that ERCC6L expression is markedly significant for the prognosis of HCC patients.

also in 476 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.